newsfilter
← Latest News
PR Newswire·

AbbVie Named Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team, Launches AbbVie Race to Innovate to Support Immunology Community

  • AbbVie becomes the Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team in a multi-year collaboration.
  • The partnership launches "AbbVie Race to Innovate" at the 2026 Formula 1 United States Grand Prix in Austin.
  • AbbVie will donate $10,000 to global charities for every 10 Constructors' Championship points earned by McLaren.
  • Donations will support patient advocacy organizations serving people living with immune-mediated diseases.
  • The campaign aims to reflect the approximate 10% of the global population impacted by autoimmune diseases.
  • Race to Innovate will expand throughout the full 2027 Formula 1 season with ongoing donations, storytelling, & fan engagement.
  • The initiative connects McLaren's on-track performance with AbbVie's mission to advance innovation in immunology.